Related Experiment Video

Updated: Mar 16, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.6K

Dominant-side onset in Parkinson's disease and better motor performance?

Young H Sohn1, Jee H Ham2

  • 1Department of Neurology, Yonsei University College of Medicine, Seoul, Korea. yhsohn62@yuhs.ac.

Movement Disorders : Official Journal of the Movement Disorder Society
|August 23, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K

Related Experiment Videos

Last Updated: Mar 16, 2026

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease
06:45

Rating L-DOPA-Induced Dyskinesias in the Unilaterally 6-OHDA-Lesioned Rat Model of Parkinson's Disease

Published on: October 4, 2021

3.6K
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
11:12

Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation

Published on: July 16, 2014

23.2K
Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease
05:51

Induction and Assessment of Levodopa-induced Dyskinesias in a Rat Model of Parkinson's Disease

Published on: October 14, 2021

4.6K

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

1.3K
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.3K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

2.3K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
2.3K
Neural Regulation01:37

Neural Regulation

44.0K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
44.0K

Articles linked to this work by shared authors, journal, and citation graph.

Quantitative Analysis of Automatically Segmented Perivascular Space in Subcortical White Matter of Parkinson's Disease: Its Clinical Relevance.

Journal of movement disorders·2026

Amyloid-linked trajectories of cerebral hypoperfusion and dopamine loss in dementia with Lewy bodies.

Brain : a journal of neurology·2026

Greater Motor and Nonmotor Burden at Diagnosis Is Associated With Amyloid Copathology in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Cerebellum crus II cortical thickness as a cognitive brain reserve in Parkinson's disease.

Parkinsonism & related disorders·2026

Spatiotemporal Progression Patterns of Striatal Dopamine Depletion and Cerebral Hypoperfusion in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Language impairment as a risk factor for dementia conversion in parkinson's disease with mild cognitive impairment: a quantitative EEG study.

Journal of neural transmission (Vienna, Austria : 1996)·2026

The Costs of Parkinson's Disease in Europe: Results of the Costs of Illness in Neurology Initiative.

Movement disorders : official journal of the Movement Disorder Society·2026

Decoding Sleep Architecture from Ambulatory Basal Ganglia Signals in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Phase 2a Randomized Controlled Trial of TPN-101, A Nucleoside Reverse Transcriptase Inhibitor, in Progressive Supranuclear Palsy.

Movement disorders : official journal of the Movement Disorder Society·2026

Integrative Multi-Omics Analysis Reveals Convergent Epigenome and Transcriptome Changes in Parkinson's Disease.

Movement disorders : official journal of the Movement Disorder Society·2026

Evolution of Epidemiological Studies in Movement Disorders.

Movement disorders : official journal of the Movement Disorder Society·2026

Apathy in Lewy Body Disorders: A Position Paper.

Movement disorders : official journal of the Movement Disorder Society·2026

Flexor tenodesis for the correction of sagittal and axial plane lesser toe deformities at the metatarsophalangeal joint: A technical tip.

Foot (Edinburgh, Scotland)·2026

Effectiveness of Single-Use Negative Pressure Wound Therapy (Pico 7) in Chronic Lower Limb Wounds: A Randomized Clinical Trial.

Journal of clinical medicine·2026

Quality of Life, Active Ageing, Social Support and Loneliness in Older Adults Attending Day Centres: A Descriptive Analysis.

Healthcare (Basel, Switzerland)·2026

See the (In)Visible: Infrared Thermography for Characterizing Thermal Patterns Associated with Peripheral Arterial Disease and Diabetes Mellitus.

Medical sciences (Basel, Switzerland)·2026

Bidirectional Limb Salvage and Its Impact on Residual Limb Survivorship: Is a Partial Calcanectomy in Ambulatory Midfoot Amputees Worthwhile?

Journal of the American Podiatric Medical Association·2026

Longitudinal Change in Disability and Functioning in Patients With Moderate-to-Severe Parkinson's Disease: A Population-Based Assessment Using the World Health Organization Disability Assessment Schedule 2.0.

Asia-Pacific journal of public health·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us